Update on the advances and challenges in bioequivalence testing methods for complex topical generic products

Area of Science:

• Dermatology
• Pharmaceutical Sciences
• Regulatory Science

Background:

• Government agencies like the US FDA and EMA require bioequivalence proof for generic topical products.
• Assessing bioequivalence in complex topical dermatological formulations presents significant challenges.
• Traditional clinical studies, while gold standard, are expensive and may lack sensitivity for formulation differences.

Purpose of the Study:

• To review current human bioequivalence determination methods for topical formulations.
• To highlight recent advancements in bioequivalence testing methodologies for topical products.
• To discuss the limitations of various bioequivalence assessment techniques.

Main Methods:

• Review of existing literature on topical formulation bioequivalence.
• Analysis of alternative methods beyond comparative clinical studies.
• Emphasis on recent technological and methodological advancements.

Main Results:

• Alternative methods are increasingly validated for topical bioequivalence testing.
• These methods are often sensitive, reproducible, and cost-effective.
• They can expedite the availability of generic topical dermatological products.

Conclusions:

• Advanced alternative methods offer viable solutions for topical bioequivalence assessment.
• These approaches can reduce the financial burden and time associated with clinical trials.
• A detailed understanding of method limitations is crucial for accurate bioequivalence determination.